Home LiteratureArticle Details
PMID: 17261614 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.

Infection and immunity ·Vol. 75 ·No. 5 ·2007-05-00 ·Pages 2214-24

Jelsbak L, Johansen HK, Frost AL, Thøgersen R, Thomsen LE, Ciofu O, Yang L, Haagensen JA, Høiby N, Molin S

Abstract

The ability to establish lifelong persistent infections is a fundamental aspect of the interactions between many pathogenic microorganisms and their mammalian hosts. One example is chronic lung infections by the opportunistic pathogen Pseudomonas aeruginosa in cystic fibrosis (CF) patients. This infection process is associated with extensive genetic adaptation and microevolution of the infecting bacteria. Through investigations of P. aeruginosa populations and infection dynamics in a group of CF patients followed at the Danish CF Clinic in Copenhagen, we have identified two distinct and dominant clones that have evolved into highly successful colonizers of CF patient airways. A significant component of the evolutionary success of these two clones has been their efficient transmissibility among the CF patients. The two clones have been present and transmitted among different CF patients for more than 2 decades. Our data also suggest that the P. aeruginosa population structure in the CF patient airways has been influenced by competition between different clones and that the two dominant clones have been particularly competitive within the lungs, which may add to their overall establishment success. In contrast, we show that adaptive traits commonly associated with establishment of chronic P. aeruginosa infections of CF patients, such as transition to the mucoid phenotype and production of virulence factors, play minor roles in the ability of the two dominant clones to spread among patients and cause long-term chronic infections. These findings suggest that hitherto-unrecognized evolutionary pathways may be involved in the development of successful and persistent P. aeruginosa colonizers of CF patient lungs.

MeSH Terms
Adolescent Adult Child Child, Preschool Chronic Disease/epidemiology Cystic Fibrosis/epidemiology,microbiology Denmark/epidemiology Electrophoresis, Gel, Pulsed-Field Female Genetic Variation Genotype Humans Lung/microbiology Male Molecular Epidemiology Pseudomonas Infections/epidemiology,microbiology Pseudomonas aeruginosa/classification,genetics,pathogenicity
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Jelsbak Lars
Infection Microbiology Group, BioCentrum-DTU, Technical University of Denmark, Building 301, 2800 Lyngby, Denmark.
Johansen Helle Krogh
Frost Anne-Louise
Thøgersen Regitze
Thomsen Line E
Ciofu Oana
Yang Lei
Haagensen Janus A J
Høiby Niels
Molin Søren
References (43)
43 references, click to expand
  1. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Eur Respir J. 2005 Sep;26(3):458-61 PMID: 16135728
  2. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients.
    Clin Microbiol Infect. 2001 May;7(5):238-43 PMID: 11422250
  3. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
    J Pediatr. 2001 May;138(5):699-704 PMID: 11343046
  4. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.
    Infect Immun. 2005 Apr;73(4):2504-14 PMID: 15784597
  5. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Lancet. 1996 Sep 7;348(9028):639-42 PMID: 8782753
  6. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
    J Antimicrob Chemother. 1986 Apr;17(4):505-16 PMID: 3086274
  7. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Infect Immun. 1998 Jan;66(1):280-8 PMID: 9423869
  8. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.
    Infect Immun. 1997 Sep;65(9):3838-46 PMID: 9284161
  9. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
    Proc Natl Acad Sci U S A. 2006 May 30;103(22):8487-92 PMID: 16687478
  10. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.
    J Bacteriol. 1994 Nov;176(21):6677-87 PMID: 7961421
  11. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis.
    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):715-20 PMID: 9892699
  12. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.
    J Hosp Infect. 1997 Jun;36(2):117-22 PMID: 9211158
  13. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
    Pediatr Pulmonol. 2004 May;37(5):427-32 PMID: 15095326
  14. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
    Lancet. 2001 Aug 18;358(9281):557-8 PMID: 11520529
  15. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
    Thorax. 2002 Jun;57(6):559-60 PMID: 12037234
  16. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Acta Pathol Microbiol Scand Suppl. 1977;(262):1-96 PMID: 411327
  17. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
    Pediatr Res. 1987 Oct;22(4):429-31 PMID: 2891100
  18. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.
    J Clin Microbiol. 1996 May;34(5):1129-35 PMID: 8727889
  19. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.
    Thorax. 1992 Feb;47(2):109-11 PMID: 1549817
  20. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.
    Am J Respir Crit Care Med. 2002 Oct 1;166(7):983-7 PMID: 12359658
  21. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.
    Pediatr Pulmonol. 2000 Mar;29(3):177-81 PMID: 10686037
  22. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.
    J Bacteriol. 2005 Jul;187(14):4908-20 PMID: 15995206
  23. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    J Infect Dis. 2001 Feb 1;183(3):444-52 PMID: 11133376
  24. Caenorhabditis elegans is a model host for Listeria monocytogenes.
    Appl Environ Microbiol. 2006 Feb;72(2):1700-1 PMID: 16461732
  25. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.
    J Med Microbiol. 2004 Jul;53(Pt 7):609-15 PMID: 15184530
  26. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
    Pediatr Pulmonol. 1997 May;23(5):330-5 PMID: 9168506
  27. An Organ-Specific Differentiation Gene, pha-1, from Caenorhabditis elegans.
    Science. 1990 Nov 2;250(4981):686-8 PMID: 17810870
  28. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Thorax. 1992 Jan;47(1):6-13 PMID: 1539148
  29. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.
    J Clin Microbiol. 2002 Aug;40(8):2772-8 PMID: 12149328
  30. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    J Infect Dis. 1994 Dec;170(6):1616-21 PMID: 7996008
  31. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    J Clin Microbiol. 2005 Oct;43(10):5247-55 PMID: 16207991
  32. Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping.
    J Bacteriol. 2004 Jul;186(13):4228-37 PMID: 15205425
  33. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.
    Infect Immun. 1994 Feb;62(2):596-605 PMID: 8300217
  34. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8377-81 PMID: 8378309
  35. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
    Eur Respir J. 2004 Jul;24(1):101-6 PMID: 15293611
  36. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
    Pediatr Pulmonol. 2002 Oct;34(4):257-61 PMID: 12205566
  37. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.
    Appl Environ Microbiol. 1994 Jun;60(6):1734-8 PMID: 8031075
  38. Short-sighted evolution and the virulence of pathogenic microorganisms.
    Trends Microbiol. 1994 Mar;2(3):76-81 PMID: 8156275
  39. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.
    Pediatr Pulmonol. 2001 Oct;32(4):288-92 PMID: 11568989
  40. Conserved virulence factors of Pseudomonas aeruginosa are required for killing Bacillus subtilis.
    J Microbiol. 2005 Oct;43(5):443-50 PMID: 16273037
  41. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
    Thorax. 2004 Apr;59(4):334-6 PMID: 15047956
  42. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
    J Med Microbiol. 2003 Sep;52(Pt 9):731-40 PMID: 12909647
  43. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    APMIS. 1993 Feb;101(2):168-75 PMID: 8098219
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2007-05-00
Epub
2007-00-29
Pages
2214-24
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1865789
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com